| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |